natgillin/translations-raw huggingface dataset:
Hе е установена ефективността на Арипипразол Accord за лечение на шизофрения и биполярно афективно разстройство при пациенти на и над 65 годишна възраст.
The effectiveness of Aripiprazole Accord in the treatment of schizophrenia and Bipolar I Disorder in patients aged 65 years and older has not been established.
Hе се изисква промяна на дозата при пациенти с бъбречно нарушение.
No dosage adjustment is required in patients with renal impairment.
Hе се изисква промяна на дозата при пациенти с бъбречно нарушение.
Νο dosage adjustment is required in patients with renal impairment.
Hевролептичен малигнен синдром (NMS) Генерализирани тонично- клонични припадъци тип „grand mal„
Neuroleptic Malignant Syndrome (NMS)
Hивата на медта в урината обикновено се повишават с хелираща терапия като пенициламин или триентин.
Urinary copper levels are usually increased with chelation therapy such as penicillamine or trientine.
I allmänhet liknade emtricitabins farmakokinetik hos HBV-infekterade individer den hos friska och hos hiv-infekterade individer.
In general, emtricitabine pharmacokinetics in HBV infected subjects were similar to those in healthy subjects and in HIV infected subjects.
i blodet
dehydrogenase
I denna bipacksedel finns information om följande
What is in this leaflet
I denna bipacksedel finns information om följande:
What is in this leaflet:
I denna situation ska du inte ta läkemedel som stoppar eller lugnar tarmaktiviteten.
In this situation, you should not take medicines that stop or slow bowel movement.
I en 21 dagars studie administrerades fluoxetin dagligen med en dos på 0,75, 1,5 och 3,0 mg/kg till laboratoriebeaglar.
In a 21 day study, fluoxetine was administered daily at a dose of 0.75, 1.5 and 3.0 mg/kg to laboratory Beagles.
I en pilotstudie hos barn och en definitiv bioekvivalensstudie hos vuxna visade sig Emtriva 10 mg/ml oral lösning ha cirka 80 % av biotillgängligheten av Emtriva 200 mg hårda kapslar.
In a pilot study in children and a definitive bioequivalence study in adults, the Emtriva 10 mg/ml oral solution was shown to have approximately 80% of the bioavailability of the Emtriva 200 mg hard capsules.
I enlighet med god djurhållning rekommenderas rengöring och desinficering av de infekterade fåglarnas miljö med en lämplig svampdödande produkt.
In accordance with good animal husbandry, the cleaning and disinfection of the infected birds’ environment with an appropriate antifungal product is recommended.
I enlighet med god djurhållning rekommenderas rengöring och desinficering av de infekterade fåglarnas miljö med en lämplig svampdödande produkt.
In accordance with good animal husbandry, the cleaning and disinfection of the infected birds’ environment with an appropriate antifungal product should be recommended.
I fall av oavsiktligt intag uppsök genast läkare och visa bipacksedeln eller förpackningen.
In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
I fall av överdosering ska symptomatisk behandling initieras.
In the case of overdose symptomatic treatment should be initiated.
I fall av överdosering ska symtomatisk behandling initieras.
In case of overdose symptomatic treatment should be initiated.
I fyra kliniska huvudstudier behandlades 1 305 vuxna patienter med Zinforo (600 mg administrerat under 60 minuter var 12:e timme).
In four pivotal clinical trials, 1305 adult patients were treated with Zinforo (600 mg administered over 60 minutes every 12 hours).
I händelse av oavsiktlig självinjektion skall läkare kontaktas omedelbart och bipacksedel eller förpackning uppvisas.
In case of accidental ingestion, seek medical advice immediately and show this package leaflet or the label to the physician.
I händelse av oavsiktlig självinjektion skall läkare kontaktas omedelbart och bipacksedel eller förpackning uppvisas.
In case of accidental self-injection, seek medical advice immediately and show this package leaflet or the label to the physician.
I händelse av oavsiktligt intag ska läkare kontaktas omedelbart och bipacksedel eller förpackning uppvisas.
In case of accidental ingestion, seek medical advice immediately and show this package leaflet or the label to the physician.
I in vivo-studier på hundar har maropitants antiemetiska effekt mot centrala och perifera emetika visats, inkluderande apomorfin, cisplatin och ipekaksirap.
In vivo studies in dogs demonstrated the anti-emetic efficacy of maropitant against central and peripheral emetics including apomorphine, cisplatin and syrup of ipecac.
I IntronA (3 MIU 3 пъти седмично)
I IntronA (3 MIU 3 times a week)
I kliniska studier gav maropitants plasmanivåer effekt från och med 1 timme efter administreringen.
During clinical studies maropitant plasma levels conferred efficacy from 1 hour after administration.
I kliniska studier gav maropitants plasmanivåer effekt från och med 1 timme efter administreringen.
During clinical studies maropitant plasma levels conferred efficacy from 1 hour after administration..
I kliniska studier har effekten av ceftarolin påvisats in vitro mot de patogena organismer som räknas upp under respektive indikation:
Efficacy has been demonstrated in clinical studies against the pathogens listed under each indication that were susceptible to ceftaroline in vitro.
I kliniska studier upphörde dessa biverkningar omedelbart efter intravenös tillförsel av en standarddos med diazepam.
In clinical studies these side effects were stopped immediately upon intravenous administration of a standard dose of diazepam.
I kombinationsstudier med emtricitabin och proteashämmare samt hämmare av hiv omvänt transkriptas (nukleosid-, nukleotid- och icke-nukleosidanaloger) observerades additiva till synergistiska effekter.
In combination studies of emtricitabine with protease inhibitors, nucleoside, nucleotide and non-nucleoside analogue inhibitors of HIV reverse transcriptase, additive to synergistic effects were observed.
I laboratorietester har maropitant visat tendens att orsaka ögonirritation.
In laboratory studies, maropitant has been shown to be a potential eye irritant.
I likhet med andra antimikrobiella betalaktamsubstanser har den procentuella tiden över minsta hämmande koncentration (MIC) för den infekterande organismen över doseringsintervallet ( %T > MIC) visat sig vara den parameter som bäst korrelerar med den antimikrobiella effekten för ceftarolin.
As with other beta-lactam antimicrobial agents, the percent time above the minimum inhibitory concentration (MIC) of the infecting organism over the dosing interval (%T > MIC) has been shown to be the parameter that best correlates with the efficacy of ceftaroline.
I läkemedlets tryckta bipacksedel ska namn och adress till tillverkaren som ansvarar för frisläppandet av den relevanta tillverkningssatsen anges.
The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.‌
I meget sjældne tilfælde kan der opstå nedstemthed.
In very rare cases depression may develop.
I meget sjældne tilfælde kan der udvikles en absces på injektionsstedet eller i de lokale lymfeknuder.
In very rare cases an abscess may develop at the injection site or in the regional lymph nodes.
I mycket sällsynta fall har allvarliga (livshotande) anafylaktiska reaktioner observerats.
In very rare cases anaphylactoid reactions which may be serious (including fatal) may occur and should be treated symptomatically.
I mycket sällsynta fall har allvarliga (livshotande) anafylaktiska reaktioner observerats.
In very rare cases anaphylactoid reactions, which may be serious (including fatal), may occur and should be treated symptomatically.
I mycket sällsynta fall har allvarliga anafylaktoida reaktioner (inklusive sådana som leder till döden) rapporterats och dessa ska behandlas symptomatiskt.
In very rare cases anaphylactoid reactions, which may be serious (including fatal), may occur and should be treated symptomatically.
I mycket sällsynta fall har anafylaktoida reaktioner som kan vara allvarliga (inklusive livshotande) rapporterats och som bör behandlas symptomatiskt.
In very rare cases anaphylactoid reactions which may be serious (including fatal) may occur and should be treated symptomatically
I mycket sällsynta fall har aptitlöshet, letargi, buksmärtor och kolit rapporterats.
In very rare cases loss of appetite, lethargy, abdominal pain and colitis have been reported.
I mycket sällsynta fall har aptitlöshet, sömnighet, buksmärtor och kolit rapporterats.
In very rare cases loss of appetite, lethargy, abdominal pain and colitis have been reported.
I mycket sällsynta fall har blodig diarré, blodig kräkning, sår i magtarmkanalen och förhöjda leverenzymer rapporterats.
In very rare cases, haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported.
I mycket sällsynta fall har blodig diarré, blodiga kräkningar, sår i magtarmkanalen och förhöjda leverenzymer rapporterats.
In very rare cases haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported.
I mycket sällsynta fall har förhöjda leverenzymer rapporterats.
In very rare cases elevated liver enzymes have been reported.
I mycket sällsynta fall kan allvarliga anafylaktoida reaktioner uppträda (inklusive sådana som leder till döden) och dessa ska behandlas symptomatiskt.
In very rare cases anaphylactoid reactions, which may be serious (including fatal), may occur and should be treated symptomatically.
I mycket sällsynta fall kan anafylaktoida reaktioner uppträda och bör behandlas symptomatiskt.
In very rare cases, anaphylactoid reactions may occur and should be treated symptomatically.
I mycket sällsynta fall kan anafylaktoida reaktioner uppträda som bör behandlas symptomatiskt.
In very rare cases anaphylactoid reactions may occur and should be treated symptomatically.
I mycket sällsynta fall kan anafylaktoida reaktioner uppträda som kan vara allvarliga (och livshotande) och som bör behandlas symptomatiskt.
In very rare cases anaphylactoid reactions which may be serious (including fatal), may occur and should be treated symptomatically.
I mycket sällsynta fall kan aptitlöshet, letargi, abdominalsmärtor och kilit uppträda.
In very rare cases loss of appetite, lethargy, abdominal pain and colitis have been reported.
I mycket sällsynta fall kan aptitlöshet, sömnighet, abdominalsmärtor och kilit uppträda.
In very rare cases loss of appetite, lethargy, abdominal pain and colitis have been reported.
I mycket sällsynta fall kan en övergående, akut överkänslighetsreaktion inträffa.
In very rare cases a transient acute hypersensitivity reaction may occur.
I mycket sällsynta fall kan hemorragiska diarré, hematemes, gastrointestinala ulceration och förhöjda leverenzymer uppträda.
In very rare cases haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported.
I mycket sällsynta fall kan hemorragiska diarré, hematemes, gastrointestinala ulceration och förhöjda leverenzymer uppträda.
In very rare cases, haemorrhagic diarrhoea, haematemesis, gastrointestinal ulceration and elevated liver enzymes have been reported.
I mycket sällsynta fall, har kliniska tecken på immunmedierad hemolytisk anemi (ökad nedbrytning av röda blodkroppar), immunmedierad trombocytopeni (minskad mängd blodplättar), eller immunmedierad polyartrit (inflammation i leder) rapporterats.
In very rare cases, clinical signs of immune-mediated haemolytic anaemia, immune-mediated thrombocytopenia, or immune-mediated polyarthritis have been reported.
I mycket sällsynta fall, har kliniska tecken på immunmedierad hemolytisk anemi, immunmedierad trombocytopeni, eller immunmedierad polyartrit rapporterats.
In very rare cases, clinical signs of immune-mediated haemolytic anaemia, immune-mediated thrombocytopenia, or immune-mediated polyarthritis have been reported.
I poolade humana levermikrosomer var den metabola omsättningen låg för ceftarolin, vilket tyder på att ceftarolin inte metaboliseras via hepatiska CYP450-enzymer.
In pooled human liver microsomes, metabolic turnover was low for ceftaroline, indicating that ceftaroline is not metabolised by hepatic CYP450 enzymes.
I sex kliniska prövningar i fas 2 och fas 3 behandlades 1588 vuxna patienter med Zavicefta.
In six Phase 2 and Phase 3 clinical trials, 1588 adult patients were treated with Zavicefta.
I sjældne tilfælde kan der observeres appetitløshed, feber, kulderystelser og spredte ødematøse hævelser (f.eks. ødem i hovedet, hævet mule/overlæbe).
In rare cases, inappetence, fever, shivering and diffuse oedematous swellings (e.g. facial oedema, swollen muzzle/upper lip) may be observed.
I studierna på vuxna fick 1 039 tidigare obehandlade och 440 tidigare behandlade patienter emtricitabin (n = 814) eller jämförelsesubstans (n = 665) under 48 veckor i kombination med andra antiretrovirala läkemedel.
In the adult studies, 1,039 treatment-naïve and 440 treatment-experienced patients received emtricitabine (n = 814) or comparator medicinal product (n = 665) for 48 weeks in combination with other antiretroviral medicinal products.
I tilfælde af uønsket hændelser.
In case of adverse events.
I två studier av patienter med cUVI, hade 381/1091 (34,9 %) patienter cUVI utan pyelonefrit medan 710 (65,1 %) hade akut pyelonefrit (mMITT-population).
In two studies in patients with cUTI, 381/1091 (34.9%) patients were enrolled with cUTI without pyelonephritis while 710 (65.1%) were enrolled with acute pyelonephritis (mMITT population).
I två studier av patienter med komplicerade intraabdominella infektioner var den vanligaste diagnosen (cirka 42 %) perforation av appendix eller peri-appendikulär abscess.
In two studies in patients with cIAI, the most common diagnosis (approximately 42%) was appendiceal perforation or peri-appendiceal abscess.
I Viraferon (3 MIU 3 пъти седмично)
I Viraferon (3 MIU 3 times a week)
I Интерферон алфа-2b 3 MIU
I Interferon alfa-2b 3 MIU
I затворен
with a butyl
i напр. хемартроза, мускулен кръвоизлив
i e.g. haemarthrosis, muscle haemorrhage
I-03012 Anagni-Frosinone - Италия
I-03012 Anagni-Frosinone - Italy
I-04010 Borgo San Michele (Latina) Италия
I-04010 Borgo San Michele (Latina) Italy
I-04010 Campoverde di Aprilia
I-04010 Campoverde di Aprilia (Latina)
I-10044 Pianezza Италия
I-10044 Pianezza Italy
I-20090 Segrate (Milano)
I-20090 Segrate (Milano) Tel: + 39-02 21018.1
I-20090 Segrate (Milano) Tel: + 39-02 21018.1
I-20090 Segrate (Milano)
I-36100 Vicenza(VI) - Италия
I-36100 Vicenza(VI) - Italy
I-70026 Modugno (Bari) Италия
I-70026 Modugno (Bari) Italy
I-70026 Modugno (Bari), Италия
I-70026 Modugno (Bari) Italy
I-80058 Torre Annunziata - Napoli Италия
I-80058 Torre Annunziata - Napoli Italy
I-80058 Torre Annunziata/NA
I-80058 Torre Annunziata/NA Italy
I-80058 Torre Annunziata/NA Италия
I-80058 Torre Annunziata/NA Italy
I-Neb небулизатор
I-Neb nebuliser
i. v.
I.V. use
i.e.
IU
I.M или S.C инжектиране
I.M. or S.C. injection
i.m.
IM
I.M.
IM.
i.m. инжекция
i.m. injection
i.m. приложение
IM use
i.m./s.c.
IM/SC
i.v.
IV
i.v. = интравенозно; QD = quaque die (веднъж дневно); BID = bis in die (два пъти дневно)
IV = intravenous; QD = quaque die (once a day); BID = bis in die (twice a day)
i.v. инфузия
IV infusion
i.v. приложение
IV use
i.v. приложение
IV use.
I.v.Ig е противопоказан при пациенти със селективен IgA дефицит, където IgA дефицитът е единствения абнормен показател.
IVIg is not indicated in patients with selective IgA deficiency where the IgA deficiency is the only abnormality of concern.
I.v.Ig продуктите може да съдържат кръвногрупови антитела, които може да действат като хемолизини и да предизвикат in vivo покриване на червени кръвни клетки с имуноглобулин, водещо да позитивна директна антиглобулинова реакция (тест на Coombs) и рядко хемолиза.
IVIg products can contain blood group antibodies which may act as haemolysins and induce in vivo coating of red blood cells with immunoglobulin, causing a positive direct antiglobulin reaction (Coombs’ test) and, rarely, haemolysis.
I.v.Ig продуктите може да съдържат кръвногрупови антитела, които може да действат като хемолизини и да предизвикат in vivo покриване на червени кръвни клетки с имуноглобулин, водещо да позитивна директна антиглобулинова реакция (тест на Coombs) и рядко хемолиза.
IVIg products can contain blood group antibodies which may act as haemolysins and induce in vivo coating of red blood cells with immunoglobulin, causing a positive direct antiglobulin reaction (Coomb’s test) and, rarely, haemolysis.
I/R IntronA (3 MIU 3 пъти седмично) + рибавирин (1 000/1 200 mg/ден)
I/R IntronA (3 MIU 3 times a week) + ribavirin (1,000/1,200 mg/day)
I/R Viraferon (3 MIU 3 пъти седмично) + рибавирин (1 000/1 200 mg/дневно)
I/R Viraferon (3 MIU 3 times a week) + ribavirin (1,000/1,200 mg/day)
I13CJle)],BaHH51Ta Ca yCTaHOBHJlH, 4e t½ e npH6JlH3HTeJlHO 2-5 4aCa.
Trials have indicated a t½ of about 2-5 hours.
I13nOJl3BaHTe CaMO HrJlH C TecpJlOHOBO nOKpHTHe HJlH HrJlH OT Hepb)K)],aeMa CTOMaHa.
Use only teflon-coated or stainless steel needles.
I1H)],HBH)],yaJlHHTe HHCyJlHHOBH Hy)K)],H O6HKHOBeHO Ca Me)K)],y 0,3 )],O 1,0 IU/kg/)],eH. )],HeBHaTa Hy)K)],a
The individual insulin requirement is usually between 0.3 and 1.0 IU/kg/day.
I1HcpeKu,H51 HJlH BHCOKa TeMnepaTypa
An infection or a fever
I1HCyJlHHbT W,e )],eHCTBa nO-6bp3O, aKO Ce HH)KeKTHpa B O6JlaCTTa Ha TaJlH51Ta.
Your insulin will work more quickly if you inject it around the waist.
I239T
I242F
I242F
I242N
I242N
L243F
I303N
S304N
I317N
I317S
I317S
N320Y
I40064 Ozzano Emilia (Bologna) Tel: +39 051 6512711 info@fatro.it
40064 Ozzano Emilia (Bologna) Tel: +39 051 6512711 info@fatro.it
Iasibon 1 mg концентрат за инфузионен разтвор ибандронова киселина
Iasibon 1 mg concentrate for solution for infusion ibandronic acid
Iasibon 1 mg концентрат за инфузионен разтвор.
Iasibon 1 mg concentrate for solution for infusion
Iasibon 1 mg се доставя в опаковки, съдържащи 1 ампула (ампула 2 ml от стъкло тип I).
Iasibon 1 mg is supplied as pack containing 1 ampoule (2 ml type I glass ampoule).
Iasibon 2 mg концентрат за инфузионен разтвор
Iasibon 2 mg concentrate for solution for infusion
Iasibon 2 mg концентрат за инфузионен разтвор ибандронова киселина (ibandronic acid)
Iasibon 2 mg concentrate for solution for infusion ibandronic acid
Iasibon 2 mg се доставя в опаковки, съдържащи 1 ампула (ампула 4 ml от стъкло тип I).
Iasibon 2 mg is supplied as pack containing 1 ampoule (4 ml type I glass ampoule).
Iasibon 2 mg се предлага в опаковки, съдържащи 1 ампула (ампула 4 ml от стъкло тип I).
Iasibon 2mg is supplied as pack containing 1 ampoule (4 ml type I glass ampoule).
Iasibon 50 mg филмирани таблетки
Iasibon 50 mg film coated tablets
Iasibon 50 mg филмирани таблетки ибандронова киселина
Iasibon 50 mg film-coated tablets ibandronic acid
Iasibon 50 mg филмирани таблетки ибандронова киселина (ibandronic acid)
Iasibon 50 mg film-coated tablets ibandronic acid
Iasibon 50 mg филмирани таблетки се доставят в блистери от полиамид/Al/PVC – алуминиево фолио, съдържащи 3, 6, 9, 28 или 84 таблетки, опаковани в картонена кутия.
Iasibon 50 mg film coated tablets are supplied in Polyamide/Al/PVC - Aluminum foil blister with 3, 6, 9, 28 or 84 tablets, packaged in a cardboard box.
Iasibon 6 mg концентрат за инфузионен разтвор
Iasibon 6 mg concentrate for solution for infusion
Iasibon 6 mg концентрат за инфузионен разтвор ибандронова киселина
Iasibon 6 mg concentrate for solution for infusion ibandronic acid
Iasibon 6 mg концентрат за инфузионен разтвор ибандронова киселина (ibandronic acid)
Iasibon 6 mg concentrate for solution for infusion ibandronic acid
Iasibon 6 mg се доставя в опаковки, съдържащи 1, 5 и 10 флакона (флакон 9 ml от стъкло тип I).
Iasibon 6 mg is supplied as packs containing 1,5,10 vials (9 ml type I glass vial with a bromobutyl rubber stopper).
Iasibon действа чрез намаляване на количеството на калция, който се губи от костите.
Ibandronate works by reducing the amount of calcium that is lost from your bones.
Iasibon е безцветен, бистър разтвор.
Iasibon is a colourless, clear solution.
Iasibon е „генерично лекарство“.
Iasibon is a ‘generic medicine’.
Iasibon епоказан при възрастни за:
Iasibon is indicated in adults for
Iasibon епоказан при възрастни за:
Iasibon is indicated in adults for:
Iasibon епоказан при възрастни запрофилактика на скелетни събития (патологични фрактури, костни усложнения, изискващи лъчетерапия или хирургично лечение) при пациенти с карцином на млечната жлеза и костни метастази.
Iasibon is indicated in adults for the prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.
Iasibon концевтрат за инфузионен разтвор не трябва да се смесва с разтвори, съдържащи калций.
Calcium containing solutions should not be mixed with Iasibon concentrate for solution for infusion.
Iasibon концентрат за инфузионен разтвор трябва да се прилага под формата на интравенозна инфузия.
Iasibon concentrate for solution for infusion should be administered as an intravenous infusion.
Iasibon не трябва да се използва при деца и юноши под 18-годинишна възраст.
Iasibon should not be used in children and adolescents below the age of 18 years.
Iasibon не трябва да се използва при деца и юноши под 18-годинишна възраст.
Iasibon should not be used in children and adolescentsbelow the age of 18 years.
Iasibon не трябва да се използва при деца и юноши под 18-годишна възраст.
Iasibon should not be used in children and adolescents below the age of 18 years.
Iasibon не трябва да се прилага по време на кърмене.
Iasibon should not be used during breast feeding.
Iasibon не трябва да се прилага по време на кърмене.
Iasibon should not be used during breat-feeding.
Iasibon обикновено се прилага от лекар или друг медицински персонал, който има опит с лечението на рак той се прилага под формата на инфузия във вената
Iasibon is normally given by a doctor or other medical staff who have experience with the treatment of cancer. it is given as an infusion into your vein
Iasibon се използва при възрастни и Ви се предписва, когато имате рак на гърдата, който се е разпространил в костите Ви (нарича се “костни метастази”).
Iasibon is used in adults and prescribed to you if you have breast cancer that has spread to your bones (called ‘bone metastases’)
Iasibon се използва при възрастни и Ви се предписва, когато имате рак на гърдата, който се е разпространил в костите Ви (нарича се “костни метастази”).
Iasibon is used in adults and prescribed to you if you have breast cancer that has spread to your bones (called ‘bone metastases’).
Iasibon съдържа по-малко от 1 ммол натрий (23 мг) на флакон, т.е. практически не съдържа натрий.
Iasibon contains less than 1 mmol sodium (23 mg) per ampoule, i.e. essentially sodium free.
Iasibon таблетки съдържат лактоза и не трябва да се прилагат при пациенти с редки наследствени проблеми на непоносимост към галактоза, Lapp лактазен дефицит или глюкозо- галактозна малабсорбция.
Iasibon tablets contain lactose and should not be administered to patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.
Iasobon концентрат за инфузионен разтвор трябва да се прилага под формата на интравенозна инфузия.
Iasibon concentrate for solution for infusion should be administered as an intravenous infusion.
IBA Molecular Italy S.R.L, Monza, Италия
IBA Molecular Italy S.R.L., Monza, Italy
IBA Molecular Italy S.R.L, Rome, Италия
IBA Molecular Italy S.R.L., Rome, Italy
IBA Molecular Italy S.R.L., Udine, Италия
IBA Molecular Italy S.R.L., Udine, Italy
IBA Molecular Spain, S.A., Madrid, Испания
IBA Molecular Spain, S.A., Madrid, Spain
IBA Molecular Spain, S.A., Seville, Испания
IBA Molecular Spain, S.A., Seville, Spain
Ibaflin 3 % peroralni gel
Ibaflin 3% Oral Gel
Ibaflin 3 %, peroralni gel
Ibaflin 3% oral gel
Ibaflin 3 %, peroralni gel za pse in mačke
Ibaflin 3% oral gel for dogs and cats
Ibaflin 3 %, peroralni gel za pse in mačke
Ibaflin 3% oral gel for dogs and cats.
Ibaflin 3 %, peroralni gel za pse in mačke Ibaflin 7,5 %, peroralni gel za pse
Ibaflin 3% oral gel for dogs and cats Ibaflin 7.5% oral gel for dogs